X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3870) 3870
Publication (262) 262
Book Review (225) 225
Newsletter (86) 86
Book Chapter (19) 19
Dissertation (15) 15
Newspaper Article (8) 8
Conference Proceeding (5) 5
Magazine Article (5) 5
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3105) 3105
animals (2150) 2150
suramin - pharmacology (1971) 1971
suramin (1730) 1730
humans (1503) 1503
male (1117) 1117
rats (779) 779
mice (622) 622
pharmacology & pharmacy (589) 589
adenosine triphosphate - pharmacology (549) 549
female (543) 543
suramin - therapeutic use (530) 530
biochemistry & molecular biology (497) 497
atp (484) 484
dose-response relationship, drug (413) 413
cells, cultured (355) 355
oncology (352) 352
in vitro techniques (341) 341
adenosine triphosphate - analogs & derivatives (319) 319
adenosine triphosphate - metabolism (299) 299
neurosciences (294) 294
cells (293) 293
purinergic p2 receptor antagonists (288) 288
inhibition (282) 282
calcium - metabolism (272) 272
expression (258) 258
cell biology (251) 251
cell line (245) 245
kinetics (240) 240
antineoplastic agents - pharmacology (225) 225
physiology (224) 224
tumor cells, cultured (223) 223
pyridoxal phosphate - analogs & derivatives (220) 220
receptors (220) 220
suramin - administration & dosage (218) 218
pyridoxal phosphate - pharmacology (213) 213
cell division - drug effects (211) 211
rats, wistar (205) 205
middle aged (204) 204
receptors, purinergic p2 - metabolism (200) 200
time factors (197) 197
cancer (196) 196
enzyme inhibitors - pharmacology (196) 196
rats, sprague-dawley (193) 193
receptor (186) 186
adult (184) 184
suramin sodium (182) 182
receptors, purinergic p2 - physiology (180) 180
electric stimulation (179) 179
binding (175) 175
abridged index medicus (173) 173
research (171) 171
activation (169) 169
prostatic neoplasms - drug therapy (155) 155
rat (155) 155
trypanosomiasis, african - drug therapy (152) 152
proliferation (148) 148
purinoceptors (147) 147
extracellular atp (143) 143
in-vitro (141) 141
proteins (141) 141
suramin - adverse effects (140) 140
guinea pigs (139) 139
aged (135) 135
uridine triphosphate - pharmacology (132) 132
signal transduction (127) 127
adenosine (126) 126
muscle contraction - drug effects (126) 126
growth-factor (124) 124
old medline (123) 123
physiological aspects (123) 123
chemotherapy (121) 121
receptors, purinergic p2 - drug effects (121) 121
signal transduction - drug effects (120) 120
antineoplastic agents - therapeutic use (119) 119
cattle (115) 115
release (111) 111
suramin - metabolism (111) 111
calcium (110) 110
aids/hiv (109) 109
membrane potentials - drug effects (108) 108
mechanism (107) 107
trypanocidal agents - therapeutic use (107) 107
protein (105) 105
urology & nephrology (105) 105
phosphorylation (104) 104
purinoceptor (104) 104
rabbits (104) 104
neurons (103) 103
smooth-muscle (103) 103
suramin - analogs & derivatives (103) 103
angiogenesis (102) 102
muscle, smooth - drug effects (102) 102
binding sites (101) 101
adenosine triphosphate - physiology (100) 100
carcinoma (100) 100
apoptosis (99) 99
invitro (99) 99
responses (98) 98
triazines - pharmacology (98) 98
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3807) 3807
French (50) 50
German (50) 50
Russian (26) 26
Chinese (14) 14
Spanish (12) 12
Japanese (11) 11
Italian (7) 7
Bulgarian (6) 6
Portuguese (4) 4
Dutch (3) 3
Korean (3) 3
Turkish (2) 2
Czech (1) 1
Norwegian (1) 1
Polish (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Molecular Biology, ISSN 0022-2836, 06/2012, Volume 419, Issue 3-4, pp. 198 - 210
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, pp. e91765 - e91765
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 04/2019, Volume 849, p. 154
Previously, we showed that the synthetic nitroderivative trans-4-methyl-[beta]-nitrostyrene (T4MeN) induced vasorelaxant effects in rat isolated aortic rings.... 
Medical colleges | Physiological aspects | Suramin sodium
Journal Article
EMBO Journal, ISSN 0261-4189, 08/2001, Volume 20, Issue 15, pp. 3957 - 3966
Prion diseases are fatal and transmissible neurodegenerative disorders linked to an aberrant conformation of the cellular prion protein (PrP super(c)). We show... 
Suramin
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 2/2014, Volume 144, Issue 1, pp. 79 - 91
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 11/2010, Volume 66, Issue 6, pp. 1019 - 1029
In preclinical models, non-cytotoxic suramin (concentrations < 50 mu M) potentiates the activity of multiple chemotherapeutic agents. The present study... 
Suramin | Modulator | Chemosensitizer | Gemcitabine | Docetaxel | Non-small cell lung cancer | RANDOMIZED-TRIAL | FACTOR RECEPTORS | FIBROBLAST-GROWTH-FACTOR | NONTOXIC SURAMIN | SUPPORTIVE CARE | ONCOLOGY | PROSTATE-CANCER | ENHANCE ACTIVITY | PLATINUM-BASED CHEMOTHERAPY | 2ND-LINE TREATMENT | PHARMACOLOGY & PHARMACY | III TRIAL | Carcinoma, Non-Small-Cell Lung - radiotherapy | Lung Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Suramin - blood | Suramin - administration & dosage | Suramin - pharmacokinetics | Nomograms | Deoxycytidine - adverse effects | Chemotherapy, Adjuvant | Suramin - adverse effects | Radiotherapy, Adjuvant | Taxoids - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Non-Small-Cell Lung - surgery | Drug Administration Schedule | Deoxycytidine - administration & dosage | Treatment Outcome | Drug Synergism | Taxoids - administration & dosage | Maximum Tolerated Dose | Lung Neoplasms - surgery | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Infusions, Intravenous | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Care and treatment | Analysis | Clinical trials | Product development | Lung cancer, Non-small cell | Cancer | Index Medicus
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2012, Volume 70, Issue 1, pp. 49 - 56
Suramin, a polysulfonated naphthylurea, inhibits the actions of polypeptide growth factors including acidic and basic fibroblast growth factors (aFGF and... 
Suramin | Phase I | Medicine & Public Health | Paclitaxel | Cancer Research | Oncology | Metastatic breast cancer | Phase II | Pharmacology/Toxicology | II TRIAL | TUMORS | CHEMOTHERAPY | CELL LUNG-CANCER | CAPECITABINE | CHEMOSENSITIZER | ONCOLOGY | ENHANCE ACTIVITY | RESISTANCE | PHARMACOLOGY & PHARMACY | GROWTH-FACTOR | LOW-DOSE SURAMIN | Nausea - chemically induced | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Fatigue - chemically induced | Suramin - administration & dosage | Dose-Response Relationship, Drug | Suramin - pharmacokinetics | Neoplasm Metastasis | Leukopenia - chemically induced | Adult | Female | Suramin - adverse effects | Paclitaxel - administration & dosage | Drug Administration Schedule | Paclitaxel - adverse effects | Treatment Outcome | Fibroblast Growth Factor 2 - blood | Breast Neoplasms - drug therapy | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Breast Neoplasms - blood | Aged | Care and treatment | Clinical trials | Breast cancer | Metastasis | Antineoplastic agents | Transforming growth factors | Antimitotic agents | Chemotherapy | Product development | Fibroblast growth factors | Cancer | Tumors | Index Medicus | breast cancer | Metastatic
Journal Article
Life Sciences, ISSN 0024-3205, 06/2011, Volume 88, Issue 23-24, pp. 1039 - 1046
Journal Article
Muscle and Nerve, ISSN 0148-639X, 01/2011, Volume 43, Issue 1, pp. 82 - 87
Journal Article
Journal Article